The review examines IGF-1's role in the aging brain, Alzheimer's disease pathology, neuroinflammation, and cognition. It surveys evidence that elevated serum IGF-I levels have been linked to better cognition and overall brain health. It also cites findings that higher baseline IGF-1 levels were linked to better performance on executive function tasks in Alzheimer's patients.
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.